Recent ONCO News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/13/2026 08:47:16 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 02/12/2026 01:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:12:49 PM
- Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company • GlobeNewswire Inc. • 02/12/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 10:00:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/02/2026 02:32:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/29/2025 05:15:21 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/23/2025 09:05:39 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/22/2025 09:40:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 10:00:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2025 02:28:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:26:50 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/10/2025 09:08:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/10/2025 06:26:52 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/04/2025 09:40:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2025 04:17:30 PM
- Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms • PR Newswire (US) • 10/07/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2025 12:16:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2025 12:45:57 PM
- Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. • GlobeNewswire Inc. • 09/26/2025 12:30:00 PM
- Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement • GlobeNewswire Inc. • 09/26/2025 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2025 12:37:50 PM
- Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM • GlobeNewswire Inc. • 09/22/2025 12:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
